Ramakrishna Nirogi Selected Research

Ramakrishna Nirogi Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 05/2023 - 01/2010
6	Dementia (Dementias) 01/2023 - 02/2012
5	Narcolepsy 05/2024 - 04/2020
5	Cognitive Dysfunction 06/2021 - 01/2010
4	Pain (Aches) 08/2017 - 10/2011
4	Neuralgia (Stump Neuralgia) 08/2017 - 10/2011
3	Schizophrenia (Dementia Praecox) 01/2023 - 01/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 07/2012
2	Cataplexy 06/2021 - 04/2020
2	Body Weight (Weight, Body) 12/2017 - 10/2012
2	Hyperalgesia 07/2012 - 10/2011
1	Psychotic Disorders (Schizoaffective Disorder) 01/2023
1	Nervous System Diseases (Neurological Disorders) 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 09/2022
1	Depressive Disorder (Melancholia) 07/2022
1	Anhedonia 07/2022
1	Sleep Wake Disorders 01/2019
1	Polydipsia 04/2016
1	Memory Disorders (Memory Loss) 10/2015
1	Migraine Disorders (Migraine) 07/2013
1	Diabetic Neuropathies (Diabetic Neuropathy) 02/2013
1	Anemia 10/2012
1	Neoplasms (Cancer) 10/2011
1	Abdominal Pain (Pain, Abdominal) 10/2011
1	Painful Neuropathy 10/2011
1	Parkinson Disease (Parkinson's Disease) 01/2010
1	Atherosclerosis 06/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2007

Drug/Important Bio-Agent (IBA)

5	samelisantIBA 06/2021 - 04/2020
4	serotonin 6 receptorIBA 01/2023 - 10/2015
4	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2022 - 10/2011
4	Histamine H3 Receptors (Histamine H3 Receptor)IBA 06/2021 - 04/2020
3	OrexinsIBA 05/2024 - 01/2019
3	5-HT4 Serotonin ReceptorsIBA 05/2023 - 10/2015
2	Donepezil (Aricept)FDA LinkGeneric 01/2022 - 12/2017
2	Histamine (Histamine Dihydrochloride)FDA Link 06/2021 - 09/2020
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2017
2	1- ((2- bromophenyl)sulfonyl)- 5- methoxy- 3- ((4- methyl- 1- piperazinyl)methyl)- 1H- indole dimesylate monohydrateIBA 05/2018 - 10/2017
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2017 - 07/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 08/2017 - 07/2013
2	LigandsIBA 07/2013 - 07/2012
2	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2013 - 01/2010
2	Analgesics (Analgesic Drugs)IBA 07/2012 - 10/2011
1	solriamfetolIBA 05/2024
1	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 05/2024
1	nicotinic receptor beta2IBA 09/2022
1	Sucrose (Saccharose)IBA 07/2022
1	Memantine (Namenda)FDA Link 01/2022
1	OxadiazolesIBA 12/2021
1	SaporinsIBA 01/2019
1	polyethylene glycol 400IBA 12/2017
1	N-methylpyrrolidoneIBA 12/2017
1	Propylene Glycol (1,2 Propanediol)FDA LinkGeneric 12/2017
1	Scopolamine (Hyoscine)FDA Link 12/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2017
1	Opioid Receptors (Opioid Receptor)IBA 08/2017
1	Tapentadol FDA Link 08/2017
1	indoleIBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 04/2016
1	pyridineIBA 10/2015
1	Pregabalin (Lyrica)FDA Link 10/2015
1	Gabapentin (Neurontin)FDA LinkGeneric 10/2015
1	Prazosin (Minipress)FDA LinkGeneric 01/2015
1	gamma-Aminobutyric Acid (GABA)IBA 07/2013
1	Butyric Acid (Butanoic Acid)IBA 07/2013
1	Dopamine (Intropin)FDA LinkGeneric 07/2013
1	Nicotinic AntagonistsIBA 07/2013
1	almotriptan (Axert)FDA Link 07/2013
1	Aldehyde Reductase (Aldose Reductase)IBA 02/2013
1	epalrestatIBA 02/2013
1	Deferasirox FDA Link 10/2012
1	Chelating AgentsIBA 10/2012
1	IronIBA 10/2012
1	Tacrine (Cognex)FDA Link 10/2012
1	Nootropic Agents (Nootropics)IBA 02/2012
1	Antipsychotic Agents (Antipsychotics)IBA 02/2012
1	5- (3,6- diazabicyclo(3.2.0)heptan- 6- yl)nicotinonitrileIBA 10/2011
1	Formaldehyde (Formol)FDA Link 10/2011
1	5-(2-azetidinylmethoxy)-2-chloropyridineIBA 10/2011
1	Freund's AdjuvantIBA 10/2011
1	glutaryl-coenzyme A (glutaryl-CoA)IBA 06/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2007

Therapy/Procedure

4	Therapeutics 05/2024 - 10/2011
2	Activities of Daily Living (ADL) 12/2022 - 01/2022
2	Ligation 07/2012 - 10/2011
1	Drug Therapy (Chemotherapy) 10/2011